Corvus Pharma Com (CRVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -31,335 | 0 | N/A |
| Depreciation Amortization | 107 | 0 | N/A |
| Accounts payable and accrued liabilities | 1,240 | N/A | N/A |
| Other Working Capital | 1,832 | 0 | N/A |
| Other Operating Activity | 16,828 | 0 | 0 |
| Operating Cash Flow | $-11,328 | $0 | $N/A |
| Cash Flows From Investing Activities | |||
| Change In Deposits | -90,285 | N/A | N/A |
| PPE Investments | -1,747 | 0 | N/A |
| Investing Cash Flow | $-92,032 | $0 | $N/A |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 108 | N/A | N/A |
| Dividend Paid | 95,569 | 0 | N/A |
| Other Financing Activity | -729 | 0 | 0 |
| Financing Cash Flow | $94,948 | $0 | $N/A |
| Beginning Cash Position | 12,517 | 0 | N/A |
| End Cash Position | 4,105 | 0 | N/A |
| Net Cash Flow | $-8,412 | $0 | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -11,328 | 0 | N/A |
| Capital Expenditure | -1,747 | N/A | N/A |
| Free Cash Flow | -13,075 | 0 | 0 |